Triostat is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is Liothyronine Sodium.
Product ID | 42023-120_480ffe8b-5e43-45bc-be8b-bc5731cfbe6d |
NDC | 42023-120 |
Product Type | Human Prescription Drug |
Proprietary Name | Triostat |
Generic Name | Liothyronine Sodium |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2013-05-01 |
Marketing Category | NDA / NDA |
Application Number | NDA020105 |
Labeler Name | Par Pharmaceutical, Inc. |
Substance Name | LIOTHYRONINE SODIUM |
Active Ingredient Strength | 10 ug/mL |
Pharm Classes | l-Triiodothyronine [EPC],Triiodothyronine [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2013-05-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020105 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2013-05-01 |
Marketing Category | NDA |
Application Number | NDA020105 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2013-05-01 |
Ingredient | Strength |
---|---|
LIOTHYRONINE SODIUM | 10 ug/mL |
SPL SET ID: | 4cd4baf4-18d2-434f-b80b-4f4b19996cf9 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
42023-120 | Triostat | liothyronine sodium |
50090-0413 | Cytomel | liothyronine sodium |
43742-0956 | Liothyronine | Liothyronine Sodium |
0093-2178 | Liothyronine Sodium | Liothyronine Sodium |
0093-2179 | Liothyronine Sodium | Liothyronine Sodium |
0093-2180 | Liothyronine Sodium | Liothyronine Sodium |
0179-0238 | Liothyronine Sodium | Liothyronine Sodium |
0574-0220 | Liothyronine Sodium | Liothyronine Sodium |
0574-0222 | Liothyronine Sodium | Liothyronine Sodium |
0574-0223 | Liothyronine Sodium | Liothyronine Sodium |
16714-166 | Liothyronine sodium | Liothyronine sodium |
16714-167 | Liothyronine sodium | Liothyronine sodium |
16714-168 | Liothyronine sodium | Liothyronine sodium |
33261-964 | Liothyronine Sodium | Liothyronine Sodium |
39822-0151 | Liothyronine Sodium | Liothyronine Sodium |
42291-417 | Liothyronine Sodium | Liothyronine Sodium |
42291-418 | Liothyronine Sodium | Liothyronine Sodium |
42291-419 | Liothyronine Sodium | Liothyronine Sodium |
42794-018 | Liothyronine Sodium | Liothyronine Sodium |
42794-019 | Liothyronine Sodium | Liothyronine Sodium |
42794-020 | Liothyronine Sodium | Liothyronine Sodium |
43063-252 | Liothyronine Sodium | Liothyronine Sodium |
43063-253 | Liothyronine Sodium | Liothyronine Sodium |
43063-884 | Liothyronine Sodium | Liothyronine Sodium |
50090-3131 | Liothyronine Sodium | Liothyronine Sodium |
50090-5586 | Liothyronine sodium | Liothyronine sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TRIOSTAT 74192885 1915772 Live/Registered |
PAR PHARMACEUTICAL, INC. 1991-08-07 |
TRIOSTAT 72108054 0729439 Dead/Expired |
LE PORTE-ECHAPPEMENT UNIVERSEL S.A. (THE UNIVERSAL ESCAPEMENT LTD) 1960-11-08 |